A synthetic peptide for use as a blocking control in assays to test for specificity of MAGEA2 antibody, Alternative Names: MAGEA2 control peptide, MAGEA2 antibody Blocking Peptide, Anti-MAGEA2 Blocking Peptide, melanoma antigen family A, 2 Blocking Peptide, CT1.2 Blocking Peptide, MAGE2 Blocking Peptide, MAGEA2A Blocking Peptide, MAGEA2B Blocking Peptide, MGC131923 Blocking Peptide, MAGEA2, MAGEA-2, MAGEA 2, MAGEA-2 Blocking Peptide, MAGEA 2 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
MAGEA2
(Melanoma Antigen Family A, 2 (MAGEA2))
Hintergrund
This gene is a member of the MAGEA gene family. The members of this family encode proteins with 50 to 80 % sequence identity to each other. The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. The MAGEA genes are clustered at chromosomal location Xq28. They have been implicated in some hereditary disorders, such as dyskeratosis congenita. This gene has two identical copies at different loci. Alternatively spliced transcript variants encoding the same protein have been identified for this gene.